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Abstract. Appropriate treatment regimens play a vital role in improv-
ing patient health status. Although some achievements have been made,
few of the recent studies of learning treatment regimens have exploited
different kinds of patient information due to the difficulty in adopting
heterogeneous data to many data mining methods. Moreover, current
studies seem too rigid with fixed intervals of treatment periods cor-
responding to the varying lengths of hospital stay. To this end, this
work proposes a generic data-driven framework which can derive group-
treatment regimens from electronic medical records by utilizing a mixed-
variate restricted Boltzmann machine and incorporating medical domain
knowledge. We conducted experiments on coronary artery disease as a
case study. The obtained results show that the framework is promising
and capable of assisting physicians in making clinical decisions.
Keywords: treatment regimen, treatment learning, treatment recom-
mendation, electronic medical records
1 Introduction
The two most important issues in healthcare are disease diagnosis and treatment.
While many works have been conducted on the problem of diagnosis prediction,
the problem of learning treatment regimens has not yet been extensively studied
from the research community. This shortage becomes more serious when hospi-
tals essentially need to make efforts to adopt treatment regimens that best fit
their available resources. Additionally, it seems hard to have a fixed care plan for
a particular disease due to its high dependency on various patient conditions. As
a result, capturing treatment regimens in practice turns out to be meaningful for
not only assisting physicians in making right clinical decisions but also helping
hospitals manage their resources thoroughly.
In principle, treatment regimens could be learned based on the knowledge-
driven approach which requires medical domain or expert knowledge. It can be a
piece of information written in the literature or accumulated experience gained
by physicians during their career. While this approach seems to be reliable, tak-
ing various domain knowledge into account is costly and not straightforward in
reality. In contrast to the knowledge-driven approach, the data-driven approach
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derives treatment patterns from a large number of observations thanks to the
availability of electronic medical records in recent years. Studies followed this
approach could be found in [2, 5, 6, 8, 9].
Although many interesting results have been achieved, those studies have
simply utilized a limited subset of features while many other kinds of data are
usually omitted. Such data can be patients’ demographics, laboratory test results
or clinical notes consisting of signs and symptoms during patients’ hospitaliza-
tion. It is apparent that the more values from those data shared between two
patients, the more possibility that the patients are treated with similar regimens.
The lack of considering such valuable information simultaneously in current re-
search could be attributed to the poor-feature data used in their experiments.
Moreover, even when the above data is made available, it generally exists in form
of numerical, binary, categorical, or text format. Such a heterogeneous data is
not ready to use for many data mining methods. Another challenge stems from
the fact that treatment regimen is typically defined over periods. Each period
is distinct from others at milestones where major changes in a patient’s health
status happen that lead to a notable adjustment in subsequent prescriptions for
the patient. Therefore, given a set of prescription records, identifying suitable
treatment periods can considerably affect the learned treatment patterns.
This work aims to propose a treatment regimen learning framework which
addresses both the above challenges. Our framework first divides patients into
clusters from which treatment regimens over periods are discovered then. To
overcome the challenges of learning from mixed-type data, we employ a mixed-
variate restricted Boltzmann machine (MV.RBM) [11]. The advantage of this
model is at its robustness in transforming heterogeneous objects to their ho-
mogeneous representations. The new latent representations are in the form of
hidden binary vectors that could be further processed easily by clustering meth-
ods. To tackle the challenge of treatment period identification, we propose an
algorithm which can relatively capture significant changes in prescription indi-
cations. Moreover, we also suggest another algorithm which derives treatment
regimens from each cluster as a regimen tree. The tree can highlight frequently
prescribed drugs and infrequently prescribed drugs inside each patient cluster
which would be useful for recommending prescribed drugs to patients.
In short, the main contributions of our work are listed as follows. Firstly,
we propose a generic framework which can exploit different kinds of relevant
patient records. The framework is superior to others in terms of data utilization.
Secondly, we employ both knowledge-driven approach and data-driven approach
in our framework. The exploited medical domain knowledge is drug indications
and their importance in the treatment for a particular disease. The combination
approach used in our framework seems more feasible to deal with the longitudi-
nal property inherent in prescription records. Lastly, we propose a new way to
represent treatment regimens flexibly. Frequent drugs are learned from individ-
ual level to group level and organized as regimen trees which could be useful for
recommending possible regimens to new patients.
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2 Related Work
This section provides a brief review of studies about the treatment-related learn-
ing problem. Notable works can be found in [2,3,9]. In [3], the authors developed
a process mining method to derive clinical pathway from medical behaviors.
Their work, however, mainly focused on learning clinical procedures rather than
a detailed treatment.
Inspired by the emergence of electronic medical records, recent studies have
exploited prescription records which would provide more useful insights about
patient treatment. In [2] the authors proposed a probabilistic model that linked
patient features and treatment behaviors together to mine treatment patterns.
Their model, however, employed many hyperparameters with almost no domain
integration. This limitation undermines the model interpretability. Moreover, it
was not explicitly described in that work how the chronological order among
the learned treatment patterns related. In [9], the inspired work of our research,
treatment regimens were derived solely from a set of prescription records. While
many typical regimens could be described in an unsupervised mechanism, their
prescription-based approach appears to lack of interpretability regarding patient
profile and health conditions that lead to the derived regimens. Additionally, al-
though the authors in [9] attempted to describe the chronological order between
regimens with predefined treatment periods, their approach capture little med-
ical domain knowledge as well as seems inflexible in dealing with the varying
lengths of hospital stay. Regarding the treatment recommendation task, [9] also
presented a way to recommend typical treatment regimen for a patient based on
demographics and disease severity of patients. This approach, however, seems
hard to be applied to new patients whose disease severity may not be recognized
at the beginning dates of hospitalization.
3 Methods
In this section, we describe our framework of treatment learning problem. This
generic framework is designed for a particular disease. Our approach is based
on the assumption that a patient cohort may be divided further into groups
of more homogeneous patients who share latent characteristics underlying in
patient profile or health status. Patients in one group, therefore, are supposed
to be treated by similar care plans that share many parts in common. Fig. 1
illustrates the framework overview. It consists of two main tasks: clustering a
cohort of patients and learning treatment regimens for each resulting cluster.
3.1 Data Collection and Preprocessing
Our framework takes medical records of cured patients as trained data. We are
interested in the data that characterizes health conditions, for example, demo-
graphic information, discharge summary, and laboratory test results. It should
be noted that for longitudinal data such as discharge and laboratory indicators,
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Fig. 1. An overview of the proposed framework for learning treatment regimens.
we only collected the records at the early stage of patients since such longitudinal
data is usually not fully available for new patients at the time of admission. This
solution is based on the intuition that patients who share initial signs, symptoms
and laboratory indicators are likely to be treated in the same way.
After being filtered, patient medical records are encoded as one-hot vectors
for categorical data or are normalized to zero-mean unit-variance for numerical
data. For discharge summary, only text sections mentioning about the patient
history of illness and description about their situation at admission are pre-
ferred. We note that segmenting these sections depends on how well-structured
discharge summaries were written. In our experiment on MIMIC III database,
some clue phrases enabled this solution to become implementable. For simplic-
ity, signs and symptoms mentioned in the segmented text are extracted as new
features of the trained patients. Our framework uses the collection processing
engine (CPE) component with AggregatePlaintextFastUMLSProcessor provided
in cTAKES [7], a well-known tool specifically designed for clinical text process-
ing, to accomplish this task. It is worth noting that extracted signs and symp-
toms using this tool links to concepts in the Unified Medical Language System
(UMLS) [1], the comprehensive ontology built for the biomedical domain.
3.2 Data Representation and Patient Clustering
The encoded data obtained from the previous step contains numerical, binary or
categorical values. Such kind of mixed-type data is not ready to fit traditional
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clustering methods. Therefore, our framework employs MV.RBM, an extension
of the restricted Boltzmann machine for data transformation and representation.
MV.RBM is a RBM where visible nodes are not restricted to binary units.
Similar to the original RBM, each binary hidden unit in MV.RBM also tries
to capture latent aspects in the imhomogeneous visible units. In other words,
MV.RBM could be considered as a model to transform heterogeneous input to
homogeneous space. Let v = (v1, v2, .., vN ) denote the set of visible features and
h = (h1, h2, .., hK) be the set of hidden units. The energy function of MV.RBM
is defined more deliberately to handle the mixed variate input.
E(v,h) = −(
∑
i
Gi(vi) +
∑
k
bkhk +
∑
ik
Hik(vi)hk)
where b = (b1, b2, .., bN ) are biases vectors for hidden layer, Gi(vi) and Hik(vi)
are specified-type functions. By exploiting the conditional independence prop-
erty within nodes in a layer of bipartite structure, we can get the following
factorization equations: P (v|h) =∏Ni=1 P (vi|h), P (h|v) =∏Kk=1 P (hk|v).
The functions Gi(vi), Hik(vi) and corresponding Pi(vi|h) for each kind of
data are given as follows [11].
Gi(vi) Hik(vi) Pi(vi|h)
Binary aivi wikvi
exp(aivi+
∑
k wikhkvi)
1+exp(ai+
∑
k wikhk)
Gaussian −v2i /2σ2 + aivi wikvi N (σ2i (ai +
∑
k wikhk), σi)
Categorical
∑
m aimδm[vi]
∑
m,k aimkδm[vi]
exp(
∑
m aimδm[vi])+
∑
m,k wimkδm[vi]hk)∑
l exp(ail+
∑
k wilkhk)
where ai, aim are input bias parameters, wik, wimk are input-hidden weighting
parameters. Those with extra subscript m are dedicated for categorical features.
Fig. 2. A MV.RBM for patient records. The green, blue and orange circles represent
for binary, categorical and continuous input units. The circles with labels D,
S, L indicate demographic, signs/symptoms and laboratory data, respectively.
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In our work, we assume features in the preprocessed data are mutually in-
dependent given their latent factors. Fig. 2 illustrates our idea to utilize a
MV.RBM. We suppose demographic data could receive numerical, binary or
categorical values while extracted signs and symptoms are represented as one-
hot vectors. Indicator values are assumed to take numerical values. Once the
MV.RBM model has been learned, the computable hidden posteriors and hidden
states are extracted as transforming features for input v. Those latent vectors
could be used as input of well-known clustering algorithms. In this concrete work,
we utilize the learned binary hidden vectors and select the hierarchical cluster-
ing algorithm to divide patients into groups. We use the Hamming distance as
similarity measurement for binary vectors and the complete linkage which was
reported to give low error rate for symmetric distance measurement [10].
3.3 Treatment Period Identification
For each resulting patient cluster obtained from the previous step, prescrip-
tion records from its patients are collected to derive typical treatment regimens
over periods. We represent every drug dr in prescription of patient p as a tu-
ple drp = (name, startdate, enddate, dosage) that describes drug name, starting
date, ending date of usage and its dosage. Let Θp = {drp} be the set of drugs
given to the patient, and T p = {drp.startdate} be the ordered set of dates the
patient p was prescribed. As |T p| varies according to p, we propose an algorithm
to split each T p into the same number of treatment periods. The idea is for each
timestamp in T p, we compute an accumulated score that captures the changes
in drug indications that have been delivered to the patient so far. We observe
the plot of these scores for many patients in the clusters and decide an appro-
priate number of periods. The splitting dates for each period are the dates with
significant changes in their associated scores.
It is worth noting that in our framework the scoring function takes into
account newly prescribed drugs, re-prescribed drugs being stopped using for
a while, recently stopped using drugs, or re-prescribed drug with changes in
dosage. The aggregate score also gives different weights to those drugs based on
their indication. Given a disease de and a set of its common symptoms Sympde,
we extract from DrugBank database [12] the drugs whose indication description
directly mentions about de. We name those drugs as main drugs. Drugs with
indication mentioned in Symp are also extracted as symptom-healing drugs. Pre-
scribed drugs for the patient p therefore are classified as main drugs, symptom-
healing drugs, and unclassified drugs. The weight of each kind of drug is assigned
decreasingly according to its importance for the treatment of de. We denote
MDB, SDB as sets of main and symptom-healing drugs which are extracted
from DrugBank; wmain, wsymp, wunk as the weight for main drugs, symptom-
healing drugs, and unclassified drugs, respectively. The detailed algorithm for
scoring changes in prescribed drug indications for a patient p is presented in
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Algorithm 1. For readability, we remove the superscript p and use Set notations
in the pseudocode.
Algorithm 1: Scoring prescription records
Data: Θ, T , MDB, SDB
Result: return scores as a list of accumulated scores
Initialize U as an empty set ; . set of recently delivered drugs
Initialize scores as an empty list ;
aScore := 0 ; . the accumulated score
for each d ∈ T do
D := {dr | ∀dr ∈ Θ ∧ dr.startdate == d} ; . delivered drugs on date d
N := {dr | ∀dr ∈ D ∧ dr.name /∈ U.name} ; . newly delivered drugs
DC := {dr | ∀dr ∈ D,∃dr′ ∈ U such that dr.name ==
dr′.name ∧ dr.dosage <> dr′.dosage} ; . dosage changed drugs
S := {dr | ∀dr ∈ U ∧ dr.name /∈ D.name ∧ dr.enddate < d} ; . recently
stopped using drugs
for each d′ ∈ U do
if ∃d′′ ∈ D such that d′.name == d′′.name then
d′ := d′′ ; . update U with redelivered drugs
U := (U \ S) ∪N ; . update U with newly delivered drugs
CD := N ∪DC ∪ S ; . considering drugs for calculating scores
CMD := CD.name ∩MDB; . considering main drugs
CSD := CD.name ∩ SDB; . considering symptom-healing drugs
UD := CD.name \ (CMD ∪ CSD); . unclassified drugs
aScore = aScore+ |CMD| × wmain + |CSD| × wsymp + |UD| × wunk;
Add aScore to scores
3.4 Learning Group Treatment Regimens
The previous section has demonstrated our domain integrated algorithm which
allows prescription recorded to be divided into periods based on the associated
scores which reflect the change in the indication of prescribed drugs. In this
section, we describe how a treatment regimen over a period of a given patient
cluster is derived. We relax the chronological order of delivered drugs in a pe-
riod and restrict the element of constructed treatment regimens to drug names
only. Other information such as dosage, route, is assumed to be decided by the
physicians.
The learned regimens were organized in a tree form. Starting from the root,
we assign the most frequently prescribed drug d to its left child node and extract
prescribed drugs excluding d of the patients who were treated by d. The drug
assignment for next right child nodes will follow the similar approach applied on
prescribed drugs of those patients who were not treated by left-hand side nodes
in the same level. We recursively perform this procedure on internal nodes. To
avoid learning too complicated details of the derived tree, we only perform the
procedure until a certain level of the tree or when the number of patients treated
by the most frequent drug for the parent node is still greater than a threshold.
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Algorithm 2 presents our ideas to construct the treatment regimen tree for a
particular group of patients in a period.
Algorithm 2: Procedure for the construction of a treatment regimen tree
regimen-Tree(depth, prescData, parent, traces)
if prescData is empty or depth == maxDepth then
return
d := most frequent drugs from prescData ;
nPatients := number of patients who were treated by d;
traces[parent, d] = “↖”;
cNodePresc := prescribed records excluding d of patients treated by d ;
rNodePresc := prescribed records of patients who were not treated by d ;
if nPatients < threshold then
regimen-Tree(depth, rNodePresc, parent, traces);
else
regimen-Tree(depth+ 1, cNodePresc, d, traces);
regimen-Tree(depth, rNodePresc, parent, traces);
return ;
4 Experimental Evaluation
This section presents our experimental evaluation of the proposed framework
for deriving typical treatment regimens from electronic medical records. The
obtained results of the clustering analysis, treatment period identification and
learned treatment regimen trees are also given and analyzed. Lastly, we propose
a method to evaluate the efficacy of the derived treatment regimen trees in
recommending prescribed drugs for new patients.
4.1 Experimental Design
Our experimental evaluation was performed on MIMIC III, a freely accessible
critical care database [4]. We considered the treatment regimen of patients who
were diagnosed with coronary artery disease as a case study. Since a patient
could be diagnosed with multiple ICD codes, to ensure the homogeneity of our
patient cohort, we only selected those whose primary ICD is coronary artery
disease and comorbidity scores are zero for other disease groups. In addition,
patients who were prescribed fewer than three times were also excluded from
the experimental evaluation. The number of extracted patients is 707 of which
we randomly selected 687 patients for training and left 20 patients for testing
the efficacy of the learned treatment regimens. We followed the approach de-
scribed in the Data Representation section to preprocess raw data. A summary
of preprocessed data with illustration features is given in Table 1
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Kind of data (no.features) Sample features (data type)
Demographic info (11)
age (numerical), gender (binary)
admission type (categorical)
Laboratory data (175)
arterial blood pressure (numerical)
atrial pacemaker(numerical)
Signs and symptoms data (1466)
abdominal discomfort (binary)
ability to climb (binary)
able to sleep (binary)
Table 1. A short summary of features in the dataset
We fit preprocessed data as input for MV.RBM with 200 hidden units since
the trained error did not decrease significantly with a larger number of hidden
units. The learned binary hidden states were then extracted as representation
features for the subsequent clustering task. We employed hierarchical clustering
with parameters are described in the previous section. For the task of treatment
period identification, we extracted main drugs and symptom-healing drugs from
DrugBank database. The referred typical symptoms of coronary artery disease
in the literature are “heart attack”,“shortness of breath” and “chest pain”. We
assigned the weight of main drugs, symptom healing drugs, and unclassified
drugs to 1, 0.5 and 0.1, respectively. The threshold of cutting node in treatment
learning algorithm was set to 10 patients. In our experiment, we derived regimens
until a certain level of the tree. The depth parameter was set to 4.
4.2 Results
Fig. 3 describes a dendrogram of clustering results. It is noted that the trained
patients themselves are homogeneous subjects in terms of diagnostic perspective.
Thus, we preferred a relatively small number of clusters. Based on the visualiza-
tion, we decided to group the trained patients into six clusters. The size of each
cluster is 198, 69, 148, 43, 111 and 118 patients, respectively.
Fig. 4 presents a few randomly taken line charts of accumulative scores for
eight patients. Interestingly, most of the plots follow similar patterns. There is
Fig. 3. Dendrogram of hierarchical cluster analysis
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Fig. 4. Sample line charts of accumulative scores of randomly taken patients. For each
line chart, the vertical axis represents the accumulative scores, the horizontal
axis represents the timestamps when a patient was prescribed.
Fig. 5. Sample of learned regimen tree. The prefix “m” denotes for main drugs while
the last integer denote the number of prescribed patients.
a slight increase in scores at the beginning and the end of every treatment com-
pared to the significant change at the center interval. Therefore, we decided to
divide prescription records of trained patients into three periods. Fig. 5 illus-
trates an example of constructed regimen trees. Given a path in the tree, we
note that the order of the nodes in this path should be understood as frequency
order of drug use rather than chronological order of prescription time. It can be
seen that the visualization can provide hint-drugs probably delivered together
with a given drug. Therefore, physicians can use the learned trees as a checklist
to decide which drugs are likely and unlikely to be prescribed.
4.3 Evaluation
We evaluate the efficacy of learned regimen trees in recommending prescribed
drugs to new patients. It should be noted that patient records of the testing
set are represented by the trained MV.RBM. We consider the patients in each
resulting clusters as labeled data and assign the cluster index for test patients
based on their nearest neighbors. Given a new patient p, let p′ be his/her nearest
neighbor which has been assigned to cluster ci. The recommended drugs should
be given to p in a particular period are drugs on the path of regimen tree of ci
in the same period such that p′ was prescribed with each drug on that path.
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Let T , nP , Dˆ
tj
p , and D
tj
p denote the test set, the number of periods, the
recommended path, i.e., the set of recommended drugs for p over period tj , and
the set of prescribed drugs for p in that period, respectively. We propose two
measures to evaluate the efficacy of learned regimens for the prescription rec-
ommendation task. These measures reflect how likely Dˆ
tj
p is a subset of D
tj
p .
Dˆ
tj
p is said “correct” if it is a non empty subset of D
tj
p . In case Dˆ
tj
p has non
empty intersection with D
tj
p but not its subset, we say the set Dˆ
tj
p is “approxi-
mately correct”. We denote mcor as the percentage of recommended paths which
are “correct” and mapp as the percentage of recommended drugs actually pre-
scribed in both “correct” and “approximately correct” paths. Let IA(B) define
the indicator function which return 1 if B ⊂ A or 0 otherwise. We have:
mcor =
1
|T |×nP
∑
p∈T
∑nP
j=1 ID
tj
p
(Dˆ
tj
p ); mapp = 1|T |×nP
∑
p∈T
∑nP
j=1
|Dˆtjp ∩D
tj
p |
|Dˆtjp |
We repeated our experiment 10 times for different training and testing sets.
The obtained values of m¯cor and m¯app are 0.527 and 0.729, respectively. Al-
though the obtained values of m¯cor should be further improved, to some extent,
these measures show the efficacy of the regimen trees derived from our proposed
framework.
5 Discussion
Comparing to related works in the literature, our work obtained more interesting
results in terms of domain exploitation and knowledge representation. Rather
than defining a similarity metric by a frequency-based approach for complex
objects [9], we tracked the change of drug indication in prescribed drugs as a
hint to discover treatment periods. It can be seen that the idea fits our nat-
ural thinking on detecting patients’ treatment periods given their prescription
records. The common pattern found in Fig 4 has reconfirmed the rationality of
our proposed domain-based algorithm. Moreover, representing the learned reg-
imens in form of trees not only fully reflects the usage-frequency of drugs but
also allows doctors to quickly recognize groups of frequently and infrequently
prescribed drugs in each patient sub-cohort. Therefore, in terms of knowledge
representation, it could be said that our work is superior to [2, 9] where the
authors simply organized treatment patterns in flat form.
There are several reasons to explain the primitive results of our initial study
on the task of treatment recommendation. Firstly, it is worth noting that we
addressed the problem of treatment recommendation on MIMIC III, a practical
and very challenging dataset. Even if it has been simplified to recommend in
total up to 12 among many prescribed drugs for every patient, the problem is
still not trivial as there are hundreds of different drugs given in the prescription
records. Additionally, while our evaluation metrics directly assess whether the
recommended drugs are prescribed to new patients, it is not clearly described in
other studies how well the recommended treatments match the actual prescribed
drugs. We leave the task of improving our prediction accuracy with a more
deliberated framework for the future work.
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6 Conclusion
In this paper, we have presented a generic framework to derive treatment regi-
mens from electronic medical records. The proposed framework is novel in terms
of data utilization, domain incorporation, and regimen representation. The ex-
perimental evaluation has shown the efficacy of learned treatments for the task
of prescription recommendation. Although further improvement should be made
such as data cleaning and normalizing for clinical features, this study is a pio-
neering work which encourages researchers to exploit medical domain knowledge
and address the treatment learning problem more thoroughly.
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